Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Biohaven Therapeutics Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT06419608
- Locations
- ๐บ๐ธ
Reverie Mind, LLC, Chandler, Arizona, United States
๐บ๐ธIMA Clinical Research, Las Vegas, Nevada, United States
๐บ๐ธPillar Clinical Research, LLC, Little Rock, Arkansas, United States
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Biohaven Therapeutics Ltd.
- Target Recruit Count
- 280
- Registration Number
- NCT06384807
- Locations
- ๐บ๐ธ
City of Hope, Duarte, California, United States
๐บ๐ธUCSD Moores Cancer Center, La Jolla, California, United States
๐บ๐ธMiami Cancer institute/Baptist Health South Florida, Miami, Florida, United States
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Biohaven Therapeutics Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT06309966
- Locations
- ๐ฎ๐น
Fondazione Policlinico Universitario A Gemelli-Rome, Roma, Italy
๐ฎ๐นIRCCS Ospedale Pediatrico Bambino Gesรน - INCIPIT - PIN, Rome, Italy
๐ฎ๐นAzienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Biohaven Therapeutics Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT06132893
- Locations
- ๐บ๐ธ
Barrow Neurological Institute, Phoenix, Arizona, United States
๐บ๐ธCenter for Neurosciences, Tucson, Arizona, United States
๐บ๐ธClinical Trials, Inc., Little Rock, Arkansas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath